1. Amgen buying drug discovery biotech Nuevolution for $167M — Novartis’ asthma drug beats GSK’s Advair in trial — Lilly’s mirikizumab succeeds in phase 2 Crohn’s trial -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 17, 2019 at 7:32 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    10,408
    Likes Received:
    3
    via Dow Jones component Johnson & Johnson (JNJ) could buy out biotech stock MeiraGTx (MGTX) for its efforts in gene therapy, an analyst suggested Friday.

    article source